Myeloid-specific KDM6B inhibition sensitizes Glioblastoma to PD1 blockade
S. Goswami, D. Raychaudhuri, P. Singh, S. M. Natarajan, Y. Chen, C. Poon, M. Hennessey, J. Zhang, S. Anandhan, B. P. Kerrigan, M. D. Macaluso, Z. He, S. Jindal, F. F. Lang, S. Basu, P. Sharma
This study shows that inhibiting KDM6B in myeloid cells improves response to PD1 blockade in glioblastoma by enhancing anti-tumor immunity.
bioRxiv · Nov 28, 2022Immunology